Compare PNTG & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PNTG | AMPH |
|---|---|---|
| Founded | 2019 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 971.8M |
| IPO Year | 2019 | 2005 |
| Metric | PNTG | AMPH |
|---|---|---|
| Price | $35.20 | $18.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $37.00 | $28.38 |
| AVG Volume (30 Days) | 227.9K | ★ 580.8K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | ★ 0.24 | 0.14 |
| Revenue | ★ $947,705,000.00 | $719,887,000.00 |
| Revenue This Year | $24.72 | $6.90 |
| Revenue Next Year | $7.61 | $4.64 |
| P/E Ratio | $146.23 | ★ $127.14 |
| Revenue Growth | ★ 36.31 | N/A |
| 52 Week Low | $21.74 | $16.65 |
| 52 Week High | $37.54 | $31.26 |
| Indicator | PNTG | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 59.51 | 39.14 |
| Support Level | $28.05 | $17.03 |
| Resistance Level | $35.13 | $24.16 |
| Average True Range (ATR) | 1.81 | 0.88 |
| MACD | 0.17 | -0.40 |
| Stochastic Oscillator | 65.44 | 17.60 |
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.